To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore

NCT01570439 · clinicaltrials.gov ↗
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

National University Hospital, Singapore